Paper Review Records
全部论文审稿周期
19 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
109
天
From budget constraints to value-based payment: an incremental cost-effectiveness analysis of sacituzumab tirumotecan for advanced triple-negative breast cancer in China
作者
Shaohong Luo; Xiangzhen Wang; Lijing Yang; Shen Lin; Xiaoting Huang; Xiuhua Weng; Xiongwei Xu展开收起
作者单位
1. Fujian Medical University; 2. Mengchao Hepatobiliary Hospital of Fujian Medical University展开收起
116
天
Pembrolizumab trough concentration monitoring and association with outcomes in advanced non-small cell lung cancer
作者
Ioannis P. Trontzas; Anastasia Palaiologou; Natalia Kamperi; Anastasia Georganta; Emmanouil Panagiotou; Ioanna-Maria Orfanou; Konstantinos G. Kyriakoulis; Ioannis Vathiotis; Elias A. Kotteas; Dimitra Grapsa; Constantin Tamvakopoulos; Konstantinos N. Syrigos展开收起
作者单位
1. National and Kapodistrian University of Athens; 2. Biomedical Research Foundation, Academy of Athens展开收起
90
天
132
天
Clinical management of oligoprogressive renal cell carcinoma
作者
Ezra A. Bernstein; Jonathan Schoenhals; Shawn Dason; Shang-Jui Wang; Eric A. Singer; Karie Runcie展开收起
作者单位
1. Columbia University Herbert Irving Comprehensive Cancer Center; 2. The Ohio State University Comprehensive Cancer Center展开收起
129
天
National Delphi consensus on perioperative and locally advanced NSCLC management in Colombia
作者
Ricardo Bruges Maya; Milton Lombana; Carlos Andres Carvajal-Fierro; Ricardo Zapata Gonzalez; Juan Jose Ortiz Martinez; Alejandro Gonzalez-Motta; Lina Maria Loaiz Salazar展开收起
作者单位
1. Instituto Nacional de Cancerología (INC); 2. Clínica de Occidente; 3. Centro de ratamiento e Investigación sobre Cáncer (CTIC); 4. Clínica CardioVID – Clínica VIDA; 5. Hospital Universitario del Valle; 6. Clínica Somer展开收起
64
天
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
